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Background: A decrease in core body temperature caused by heat distribution depends on the anesthetic agent 
used. The purpose of this study is to investigate the effects of sevoflurane and propofol on core temperature during 
laparoscopic major abdominal surgery requiring pneumoperitoneum of more than 90 min.
Methods: Fifty adult patients undergoing laparoscopic major abdominal surgery were randomly assigned to either 
a sevoflurane group (n = 25) or a propofol group (n = 25). In the sevoflurane group, anesthesia was induced with 
propofol 2 mg/kg, remifentanil 1.0 μg/kg, and maintained with 0.8-2.0 vol% sevoflurane and 0.1-0.2 μg/kg/min 
remifentanil. In the propofol group, anesthesia was induced with the effect-site concentration of propofol of 5.0 μg/
ml and remifentanil 4 ng/ml, and maintained with the effect-site concentration of propofol of 2-3.5 μg/ml and 
remifentanil 3-5 ng/ml. Core body temperature was measured with an esophageal stethoscope with a temperature 
sensor after the start of the pneumoperitoneum (baseline) and at 15-min intervals until completion of surgery.
Results: During the study period, core temperature was comparable between the two groups. When compared with 
baseline values, core temperatures in both groups were significantly decreased 45 min after pneumoperitoneum. 
Conclusions: This study demonstrated that in patients undergoing prolonged laparoscopic surgery, a decrease in 
core body temperature during sevoflurane-remifentanil anesthesia was not different than propofol-remifentanil 
anesthesia, and the incidence of hypothermia of the two groups did not differ. (Korean J Anesthesiol 2011; 61: 133-137)
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Introduction
    Hypothermia, defined as a body temperature of < 36
oC, is 
observed in approximately 60% of patients undergoing surgery 
[1]. It can lead to serious complications, including myocardial 
ischemia [2], impaired coagulation [3], increased incidence 
of surgical wound infections, and prolonged hospitalization 
[4]. Despite the absence of environmental exposure of the 
wound and abdominal viscera, hypothermia has been reported 
to occur during laparoscopic surgery [5,6]. Exposure of the 
abdominal cavity to large volumes of cold and dry carbon 
dioxide (CO2) insufflation gas has been implicated as a potential 
source of heat loss during laparoscopy [5,6].
    Both sevoflurane and propofol are used for anesthesia during 
laparoscopic surgery. Previous studies have reported that 
the decrease in core temperature during general anesthesia 
depends on the type of anesthetic [7,8]. Ikeda and colleagues [8] 
demonstrated that core temperatures in patients who received 
propofol were consistently lower than those in patients who 
received inhaled sevoflurane. However, other studies have 
reported that sevoflurane-based anesthesia did not affect 
cooling and rewarming for deliberate mild hypothermia 
compared with propofol-based anesthesia [9]. Since there are 
no data comparing the effects of sevoflurane and propofol on 
core temperature during prolonged laparoscopic surgery, this 
study investigated the effects of sevoflurane and propofol on 
core temperature during laparoscopic major abdominal surgery 
requiring pneumoperitoneum.
Materials and Methods
    After procedure approval from the institutional review board, 
adult patients undergoing laparoscopic major abdominal 
surgery gave informed consent and were studied prospectively. 
Exclusion criteria included a body mass index of more than 30 
kg/m
2, coronary occlusive disease, and respiratory insufficiency. 
Using a computer generated randomization table, 50 patients, 
ASA class I or II, were randomly assigned to either sevoflurane 
group (n = 25) or propofol group (n = 25) when they arrived 
in the operating room (OR). Laparoscopic surgeries requiring 
prolonged pneumoperitoneum time, such as gastrectomy, 
colectomy, or low anterior resection (LAR) were included in this 
study. Pneumoperitoneum pressure was maintained at a level 
of 12-15 mmHg. The room temperature was maintained at 22-
23
oC for both groups. An upper body blanket was applied to all 
patients, and when the core temperature of a patient fell below 
35.0
oC, a forced air warmer (Bair Hugger, Augustine Medical 
Inc, MN, USA) and a warming mattress with circulating water at 
38
oC were applied. 
    Patients were premedicated with an intramuscular injection 
of midazolam 2 mg and glycopyrrolate 0.2 mg. On arrival in 
the OR, standard anesthetic monitors were attached and a 
20 G catheter was inserted into the radial artery under local 
anesthesia for continuous monitoring of arterial pressure. To 
obtain a bispectral index (BIS) score, BIS monitoring (BIS VISTA 
monitor Revision 3.0, Aspect Medical Systems, Norwood, MA, 
USA) was applied prior to induction of anesthesia and a four-
electrode sensor (Quatro Sensor
TM, Aspect Medical Systems, 
Newton, MA) was placed on the forehead according to the 
manufacturer's instructions after alcohol cleaning to reduce 
skin-electrode impedance. After induction, a urinary catheter 
was inserted for measurement of hourly urine output.
    In the sevoflurane group, anesthesia was induced with 
propofol 2 mg/kg, remifentanil 1.0 μg/kg, and rocuronium 0.6 
mg/kg, and maintained with 0.8-2.0 vol% sevoflurane and 0.1-
0.2 μg/kg/min remifentanil. In the propofol group, anesthesia 
was induced with the effect-site concentration of propofol 5.0 
μg/ml and remifentanil 4 ng/ml, and rocuronium 0.6 mg/kg. A 
commercially available target controlled infusion (TCI) pump 
(Orchestra
Ⓡ, Fresenius Vial, Brezins, France) was used, and the 
pharmacokinetic sets used for calculation of target effect-site 
concentrations for propofol and remifentanil were Schnider and 
colleagues’ model [10] and Minto and colleagues’ model [11], 
respectively. The lungs were ventilated with a tidal volume of 
7-10 ml/kg and a respiratory rate of 8-12 breaths/min in order 
to maintain an end-tidal carbon dioxide tension (ETCO2) of 
30-35 mmHg at 60% inspired oxygen with air. The tidal volume 
and respiratory rate were reset to maintain an ETCO2 between 
35-40 mmHg after pneumoperitoneum in both groups. The 
anesthetic agents were maintained and adjusted with the effect-
site concentration of propofol 2-3.5 μg/ml in the propofol 
group and sevoflurane 0.8-2.0 vol% in the sevoflurane group 
to obtain BIS values between 40 and 55. None of the fluids were 
warmed. Hartmann’s solution and 6% hydroxyethyl starch in 
normal saline (NS) solution (Voluven
TM, Fresenius Kabi, Bad 
Homberg, Germany) were administered. Hartmann’s solution 
was infused at a constant rate of approximately 6 ml/kg/h. 
The maximum dose of 6% hydroxyethyl starch in NS solution 
was 50 ml/kg. Packed red blood cells were transfused when 
hemoglobin fell below 8 g/dl. 
    Hemodynamic variables, ETCO2, and temperatures were 
monitored using Datex-Ohmeda AS/3 modules. Hemodynamic 
variables were measured at 5-minute intervals using Datex-
Ohmeda S/5
TM Collect software (GE Healthcare, Helsinki, 
Finland) and recorded at 10 min after the induction of 
anesthesia (T1), 40 min after pneumoperitoneum (T2), at the 
end of surgery (T3), and 1 h after the surgery (T4). Core body 
temperature was measured with an esophageal stethoscope 
with a temperature sensor (DeRoyal Inc., Powell, TN, USA) 
after the start of pneumoperitoneum (baseline) and at 15-min 135 www.ekja.org
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intervals until the completion of surgery. Body temperature 
was also measured in the postanesthesia care unit (PACU) 
using a tympanic thermometer (ThermoScan IRT 1020, Braun, 
Germany). In PACU, a Bair Hugger forced-air warmer was app-
lied to those patients with a tympanic temperature below 36
oC. 
    Sample size calculation was performed based on a previous 
study that reported the core body temperature during laparo-
scopic abdominal surgery with sevoflurane-remifentanil 
anesthesia [12]: 90% power to detect a mean difference of 0.4
oC 
in core body temperature between sevoflurane and propofol 
anesthesia during prolonged pneumoperitoneum with a SD 
of 0.4
oC and an alpha level of 0.05 using an independent t-test. 
And, we calculated that 22 patients would be needed in each 
group. In order to compensate for an estimated dropout rate of 
10%, 25 patients for each group were recruited. 
    SPSS 13.0 (SPSS Inc, Chicago, IL, USA) was used for statistical 
analyses. All data are expressed as mean ± SD or number of 
patients. Data between the groups were compared by use of an 
independent t-test. Changes between time points within the 
group were compared using repeated measures of univariate 
analysis of variance (ANOVA) with post hoc comparisons using 
the Dunett’s test. A P value < 0.05 was considered statistically 
significant.
Results
    No significant differences between the two groups’ patient 
characteristics were observed (Table 1). No surgery was con-
verted to open laparotomy. The hemodynamic parameters 
are summarized in Table 2. During the study period, the mean 
arterial pressure and heart rate were comparable between the 
two groups, except that HR was significantly higher in the sevo-
flurane group than in the propofol group at T1. When compared 
with T1, HR was decreased at T2 and T3 in both groups.
    Temperature data from 105 min was not shown because the 
core temperature of 18 patients from the sevoflurane group 
and 22 patients from the propofol group fell below 35
oC and a 
forced air warmer was applied. Core body temperatures after 
anesthesia induction were 36.1 ± 0.5
oC and 36.0 ± 0.35
oC in the 
sevoflurane and the propofol group, respectively, and there 
was no statistically significant difference. Changes in body 
temperature after pneumoperitoneum are illustrated in Fig. 1. 
Fig. 1. Changes in core temperature during laparoscopic abdominal 
surgery. There was no significant difference between the two groups. 
*P < 0.05, vs. baseline values within the group. Baseline (0): after the 
start of pneumoperitoneum, 15-90: minutes after the insufflation of 
CO2.
Table 1.  Patient Characteristics 
Sevoflurane
 (n = 25)
Propofol 
(n = 25)
Age (yr)
Weight (kg)
Sex (M/F)
Medical history (n)
    Hypertension
    Diabetes mellitus
Anesthesia time (min)
Pneumoperitoneum time  (min)
Time interval (min)
Fluid balance, 
  intraoperative (ml)
    Crystalloid
    Colloid 
Urine output, intraoperative
Estimated blood loss
56.3 ± 7.9
61.6 ± 11.2
13/12
9
4
222 ± 67
131 ± 45
29 ± 7
1,000 [800-1,250]
500 [400-500]
155 [95-320]
300 [200-500]
59.5 ± 6.9
64.0 ± 10.4
18/7
8
4
238 ± 71
135 ± 38
32 ± 9
1,300 [950-1,750]
550 [400-775]
170 [110-272]
200 [200-400]
Values indicate mean ± SD or number of patients or median [inter-
quartile range]. Time interval: time interval from anesthesia 
induction to the start of pneumoperitoneum. 
Table 2.  Hemodynamic Parameters
T1 T2 T3 T4
MAP (mmHg)
HR (beats/min)
Sevoflurane
Propofol
Sevoflurane 
Propofol
95 ± 14
98 ± 13
77 ± 13
70 ± 8*
90 ± 14
92 ± 11
60 ± 10
†
64 ± 9
†
88 ± 15
89 ± 10
61 ± 13
†
57 ± 7
†
91 ± 14
93 ± 13
77 ± 15
74 ± 11
Values indicate mean ± SD.  MAP: mean arterial pressure, HR: heart rate, T1: 10 min after anesthesia induction, T2: 40 min after insufflation of 
CO2, T3: at the end of surgery, T4: 60 min after arrival of the post-anesthetic care unit.  *P < 0.05, vs. sevoflurane group, 
†P < 0.05, vs. baseline 
values (T1) within the group.136 www.ekja.org
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During the study period, core temperature was comparable 
between the two groups. When compared with baseline values 
(after the start of pneumoperitoneum), core temperatures 
in both groups showed a significant decrease at 45 min after 
pneumoperitoneum. Packed red blood cells warmed by an 
electric warming device were transfused into two patients of 
the sevoflurane group and one patient of the propofol group 90 
min after pneumoperitoneum. Tympanic body temperatures in 
PACU were 36.0 ± 0.6
oC and 35.9 ± 0.6
oC in the sevoflurane and 
the propofol group, respectively, and there was no statistically 
significant difference.
Discussion
    This study demonstrated that in patients undergoing pro-
longed laparoscopic surgery, the decrease in core body tem-
perature during administration of sevoflurane-remifentanil 
anesthesia did not differ in comparison with propofol-remifen-
tanil anesthesia, and the incidence of hypothermia did not 
differ between the groups.
    Hypothermia after induction of general anesthesia develops 
with a characteristic pattern consisting of three distinct phases 
[13-15]: 1) an initial rapid decrease in core temperature that 
results from core-to-peripheral redistribution of body heat; 2) a 
slower, linear decrease in core temperature caused by heat loss 
exceeding metabolic heat production; and 3) a core temperature 
plateau resulting from decreased cutaneous heat loss and 
constraint of metabolic heat to the core thermal compartment 
upon development of thermoregulatory vasoconstriction. The 
assumption of this study was that the type of anesthetic might 
affect the redistribution of body heat and cutaneous heat loss, 
as well as inhibition of thermoregulatory vasoconstriction 
during pneumoperitoneum with cold and dry CO2, so that 
the decrease of core temperature may differ according to the 
anesthetic agent chosen. 
    The effects of sevoflurane and propofol on core body tem-
perature during general anesthesia have been studied; however, 
their results remain controversial [8,9,16]. Previous studies 
have reported that core temperatures in patients who receive 
IV propofol for anesthetic induction were consistently lower 
than those in patients who received inhaled sevoflurane for 
anesthetic induction during minor oral surgery [8]. Meanwhile, 
Im and colleagues [16] demonstrated that the decrease in core 
body temperature during sevoflurane-remifentanil anesthesia 
did not differ compared with that of propofol-remifentanil 
anesthesia in female patients undergoing open hysterectomy. 
As in their report [16], we found no difference in the two groups’ 
change in core temperature during laparoscopic surgery. 
    Laparoscopic surgery has an anticipated advantage, which 
could decrease the incidence of hypothermia, because heat 
loss from exposed abdominal contents is not a factor. However, 
our study has shown that during prolonged laparoscopic 
surgery without precautionary warming methods, core 
body temperature decreased significantly from 45 min after 
pneumoperitoneum regardless of the type of anesthetics. In 
addition, Berber and colleagues [17] demonstrated that patients 
who undergo laparoscopic and open procedures of similar 
duration under endotracheal general anesthesia have similar 
profiles in terms of perioperative hypothermia.
    In humans, the heat capacity of the body is 0.812 Cal/kg 
oC 
[18]. This means that to lower the body temperature of a 60 kg 
human by 1
oC, 49 Cal should be lost. A previous study of heat 
loss during laparoscopy suggested that, assuming a theoretical 
worst-case of complete water saturation and heating of cold, 
dry inflow gas up to a flow rate of 7 L/min, the total heat loss 
would be 0.027 Cal/L [18]. In this study, the mean duration of 
gas insufflation was 130 min, the mean gas leak totaled 903 L, 
and the mean weight of patients was 63 kg. Thus, assuming a 
worst hypothetical case of complete water saturation of dry 
insufflated gas in this study, a 63 kg patient undergoing 130 
min of pneumoperitoneum with a continuous (7 L/min) gas 
leak totaling 910 L would, at worst, lose enough heat to lower 
the body temperature by 0.48
oC. Meanwhile, a previous study 
of core temperature changes in healthy volunteers undergoing 
general anesthesia alone demonstrated that core temperature 
decreased 1.6 ± 0.3
oC in the first hour of anesthesia, and, during 
the subsequent 2 h, an additional 1.1 ± 0.3
oC [14]. Therefore, 
core-to-peripheral redistribution of body heat due to general 
anesthesia might be a major contributor to the decrease of body 
temperature in this study. 
    Peripheral vasoconstriction plays a major role in the therm-
oregulatory response to reduced body temperature. Therefore, 
non-thermal factors affecting the cardiovascular system might 
modulate thermoregulatory control. Relative preservation 
of thermoregulatory vasoconstriction has been reported to 
be associated with activation of the sympathetic nervous 
system [19]. Furthermore, CO2 pneumoperitoneum could 
induce an increase in sympathetic activity, which may result 
from increased intra-abdominal pressure, hypercarbia, or an 
increased plasma concentration of catecholamine [20]. In 
addition, since Sato and colleagues [20] demonstrated that the 
choice of general anesthetic did not appear to have a major 
influence on change in the cardiac autonomic nervous system 
after induction of pneumoperitoneum, the two anesthetic 
regimens in this study might have similar thermoregulatory 
vasomotor effects during pneumoperitoneum.
    Ikeda and colleagues [8] suggested that even a very brief 
period of vasodilation during anesthetic induction causes 
substantial redistribution hypothermia. However, because 
some patients are reluctant to allow themselves to undergo the 137 www.ekja.org
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inhalational induction with sevoflurane, this technique was 
not used in the current study, although this technique might 
decrease the change in core temperature after anesthesia 
induction. However, after the same method of induction with 
IV propofol, the effects of sevoflurane and propofol on cooling 
and rewarming during deliberate mild hypothermia have been 
reported not to differ [9]. In addition, in this study, one of the 
limitations was that the post hoc power was low. Advocates of 
post hoc power recommend its use especially when a statistically 
nonsignificant result is obtained. The thinking here is that such 
a lack of significance could be due either to low power or to a 
truly small effect; if the post hoc power is found to be high, then 
the argument is made that the nonsignificance must then be 
due to a small effect size. In this study, we obtained a post hoc 
power of about 52.8% from core temperature data at 45 min 
after pneumoperitoneum. However, there are some problems 
with the use of post hoc power analyses. When a clinical trial 
leads to a negative result, the calculation of power based on the 
observed results will always lead to a low value [21]. Because of 
the significant limitations of a post hoc power analysis, many 
experts advise against calculating power after study completion 
[21-23]. It might be worth trying different anesthetic induction 
agents in future studies.
    In conclusion, this study demonstrated that after the same 
method of induction with IV propofol, sevoflurane and 
propofol cause similar changes in core temperature in patients 
undergoing laparoscopic surgery under general anesthesia. 
This study has shown that intraoperative hypothermia after 
laparoscopy developed frequently regardless of the type of 
anesthetic. Therefore, preventive measures for hypothermia 
should be considered in patients undergoing laparoscopic 
major abdominal surgery. 
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